Tetracaine
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C15H24N2O2 264.36
Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester;
2-(Dimethylamino)ethyl p-(butylamino)benzoate CAS RN®: 94-24-6; UNII: 0619F35CGV.
1 DEFINITION
Tetracaine contains NLT 98.0% and NMT 102.0% of tetracaine (C15H24N2O2 ), calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K (CN 1-May-2020)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Procedure
Prepare the standard solutions and sample solutions immediately before use or store them at a temperature of 2°–8°, and protect from light.
Solution A: 1.36 g/L of monobasic potassium phosphate in water is prepared as follows. Dissolve 1.36 g of monobasic potassium phosphate in about 600 mL of water, and add 0.5 mL of phosphoric acid. Dilute with water to 1 L.
Solution B: Acetonitrile
Solution C: 1.0 mL/L of hydrochloric acid
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
|---|---|---|
| 0 | 80 | 20 |
| 3 | 80 | 20 |
| 18 | 40 | 60 |
| 23 | 40 | 60 |
| 23.1 | 80 | 20 |
| 28 | 80 | 20 |
Diluent: Acetonitrile and Solution C (20:80)
Standard stock solution: 0.46 mg/mL of USP Tetracaine Hydrochloride RS in Diluent. Sonicate for 5 min.
Standard solution: 0.046 mg/mL of USP Tetracaine Hydrochloride RS from Standard stock solution in Diluent
Sample stock solution: 0.4 mg/mL of Tetracaine in Diluent. Sonicate for 5 min.
Sample solution: 0.04 mg/mL of Tetracaine from Sample stock solution in Diluent
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 300 nm
Column: 4.6-mm × 15-cm; 5-μm packing L1
Temperatures
Column: 30°
Autosampler: 4°
Flow rate: 1.5 mL/min
Injection volume: 10 μL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 1.5
Relative standard deviation: NMT 0.73%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of tetracaine (C15H24N2O2 ) in the portion of Tetracaine taken:
Result = (rU /rS ) × (CS /CU ) × (Mr1 /Mr2 ) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Tetracaine Hydrochloride RS in the Standard solution (mg/mL)
CU = concentration of Tetracaine in the Sample solution (mg/mL)
Mr1 = molecular weight of tetracaine, 264.36
Mr2 = molecular weight of tetracaine hydrochloride, 300.82
Acceptance criteria: 98.0%–102.0% on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
Organic Impurities
Solution A, Solution B, Solution C, Mobile phase, Diluent, and Chromatographic system: Proceed as directed in the Assay.
Standard solution: 4.6 μg/mL of USP Tetracaine Hydrochloride RS and 4 μg/mL each of USP Tetracaine Related Compound B RS, USP
Tetracaine Related Compound C RS, and USP Aminobenzoic Acid RS in Diluent
Sample solution: 1 mg/mL of Tetracaine in Diluent
System suitability
Sample: Standard solution
[Note—See Table 2 for the relative retention times.]
Suitability requirements
Resolution: NLT 5.0 between tetracaine and tetracaine related compound B
Relative standard deviation: NMT 5.0% for tetracaine
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of aminobenzoic acid, tetracaine related compound B, and tetracaine related compound C in the portion of
Tetracaine taken:
Result = (rU /rS ) × (CS /CU ) × 100
rU = peak response of corresponding tetracaine related compound from the Sample solution
rS = peak response of corresponding tetracaine related compound from the Standard solution
CS = concentration of corresponding tetracaine related compound in the Standard solution (mg/mL)
CU = concentration of Tetracaine in the Sample solution (mg/mL)
Calculate the percentage of each unspecified impurity in the portion of Tetracaine taken:
Result = (rU /rS ) × (CS /CU ) × (Mr1 /Mr2 ) × 100
rU = peak response of each unspecified impurity from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Tetracaine Hydrochloride RS in the Standard solution (mg/mL)
CU = concentration of Tetracaine in the Sample solution (mg/mL)
Mr1 = molecular weight of tetracaine, 264.36
Mr2 = molecular weight of tetracaine hydrochloride, 300.82
Acceptance criteria: See Table 2. Disregard any impurity peaks less than 0.05%.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
|---|---|---|
| Aminobenzoic acida | 0.3 | 0.4 |
| Tetracaine hydrochloride | 1 | – |
| Tetracaine related compound B | 1.7 | 0.4 |
| Tetracaine related compound C | 2.1 | 0.4 |
| Individual unspecified impurity | – | 0.4 |
| Total impurities | – | 0.8 |
a 4-Aminobenzoic acid.
5 SPECIFIC TESTS
Loss on Drying 〈731〉
Analysis: Dry under vacuum over phosphorus pentoxide for 18 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers.
USP Reference Standards 〈11〉
USP Aminobenzoic Acid RS
USP Tetracaine RS
USP Tetracaine Related Compound B RS
4-(Butylamino)benzoic acid.
C11H15NO2 193.24
USP Tetracaine Related Compound C RS
Methyl 4-(butylamino)benzoate.
C12H17NO2 207.35

